- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01958606
High Intensity Interval Training in Chronic Stroke (HIT)
April 8, 2017 updated by: Brett Kissela, University of Cincinnati
The objective of this study was to compare the effectiveness of high intensity interval training (HIT) and traditional aerobic training for persons with stroke.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants were randomized to either HIT or traditional aerobic training; each 25 minutes, 3 times per week for 4 weeks.
Outcomes were measured before and after training by a blinded rater.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45267
- University of Cincinnati
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 1) age 35-90 years
- 2) unilateral stroke experienced >6 months prior to enrollment
- 3) able to walk 10m overground with assistive devices as needed and no physical assistance
- 4) able to walk 3 minutes on the treadmill at >.13m/s (0.3mph) with no aerobic exercise contraindications
- 5) stable cardiovascular condition (American Heart Association class B, allowing for aerobic capacity <6 metabolic equivalents)
- 6) discharged from formal rehabilitation
Exclusion Criteria:
- 1) significant resting ECG abnormalities
- 2) evidence of significant arrhythmia or myocardial ischemia on treadmill ECG stress test
- 3) hospitalization for cardiac or pulmonary disease within 3 months
- 4) pacemaker or implanted defibrillator
- 5) lower extremity claudication
- 6) unable to communicate with investigators or correctly answer consent comprehension questions
- 7) severe lower extremity spasticity (Ashworth >2)
- 8) lower extremity weight bearing pain >4/10 on visual analogue scale
For the transcranial magnetic stimulation substudy, additional exclusions will also be applied. These include large cerebral infarcts or other structural defects with the potential to increase seizure risk, uncontrolled seizures, metal implants and previous craniotomy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-intensity interval training (HIT)
Treadmill exercise using bursts of concentrated effort alternated with recovery periods
|
Treadmill exercise using bursts of concentrated effort alternated with recovery periods
|
Active Comparator: Traditional aerobic training
Moderate intensity continuous aerobic exercise on a treadmill
|
Moderate intensity continuous aerobic exercise on a treadmill
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Peak Aerobic Capacity (VO2-peak)
Time Frame: Baseline and 4 weeks
|
Baseline and 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Submaximal Aerobic Capacity (VO2 at Ventilatory Threshold)
Time Frame: Baseline and 4 weeks
|
Baseline and 4 weeks
|
|
Change in Gait Velocity (10 Meter Walk Test)
Time Frame: Baseline and 4 weeks
|
Baseline and 4 weeks
|
|
Change in 6-Minute Walk Test
Time Frame: Baseline and 4 weeks
|
distance walked in 6 minutes
|
Baseline and 4 weeks
|
Change in Gait Economy (Mean Oxygen Uptake at Comfortable Walking Speed)
Time Frame: Baseline and 4 weeks
|
mean oxygen uptake at comfortable walking speed reported in units mLO2 per kilogram body weight per meter
|
Baseline and 4 weeks
|
Change in Fastest Treadmill Speed (Steep Ramp Test)
Time Frame: Baseline and 4 weeks
|
fastest safe treadmill walking speed
|
Baseline and 4 weeks
|
Change in Fractional Utilization
Time Frame: Baseline and 4 weeks
|
Metabolic cost of gait as a percentage of aerobic capacity
|
Baseline and 4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Self-Efficacy and Outcome Expectations for Exercise Scale
Time Frame: Baseline and 4 weeks
|
Baseline and 4 weeks
|
|
Change in Montreal Cognitive Assessment
Time Frame: Baseline and 4 weeks
|
Baseline and 4 weeks
|
|
Change in Gait Kinematics/Kinetics From Baseline to 4 Weeks
Time Frame: Baseline and 4 weeks
|
3D motion capture and force plates
|
Baseline and 4 weeks
|
Change in Gait Kinematics/Kinetics From Baseline to Post Session 1
Time Frame: Baseline and after session 1
|
3D motion capture and force plates
|
Baseline and after session 1
|
Change in Gait Kinematics/Kinetics During Session 1
Time Frame: During session 1
|
3D motion capture and force plates
|
During session 1
|
Change in Transcranial Magnetic Stimulation (TMS) Responses From Baseline to 4 Weeks
Time Frame: Baseline and 4 weeks
|
Primary variable is motor threshold (MT).
Secondary variables include: motor evoked potential amplitude/latency, corticomotor map size and volume and intracortical inhibition
|
Baseline and 4 weeks
|
Change in Transcranial Magnetic Stimulation (TMS) Responses Associated With Training Session 2
Time Frame: Before and after training session 2
|
Primary variable is motor threshold (MT).
Secondary variables include: motor evoked potential amplitude/latency and intracortical inhibition
|
Before and after training session 2
|
Change in Transcranial Magnetic Stimulation (TMS) Responses Associated With Training Session 12
Time Frame: Before and after training session 12
|
Primary variable is motor threshold (MT).
Secondary variables include: motor evoked potential amplitude/latency and intracortical inhibition
|
Before and after training session 12
|
Change in Daily Physical Activity (Activity Monitor)
Time Frame: Baseline and 4 weeks
|
Baseline and 4 weeks
|
|
Change in Stroke Impact Scale
Time Frame: Baseline and 4 weeks
|
Cognition Domain Score of Stroke Impact Scale.
Scores range from 0 to 100 (higher is better) and represent a sum of scores from multiple questions related to cognition.
|
Baseline and 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brett Kissela, MD, University of Cincinnati
- Principal Investigator: Kari Dunning, PhD, PT, University of Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
August 1, 2014
Study Completion (Actual)
August 1, 2014
Study Registration Dates
First Submitted
October 7, 2013
First Submitted That Met QC Criteria
October 7, 2013
First Posted (Estimate)
October 9, 2013
Study Record Updates
Last Update Posted (Actual)
May 15, 2017
Last Update Submitted That Met QC Criteria
April 8, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIT in chronic stroke
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on High-intensity interval training (HIT)
-
University of NottinghamCompletedHigh-Intensity Interval TrainingUnited Kingdom
-
University of BaselClinical Trial Unit, University Hospital Basel, SwitzerlandRecruitingHigh-intensity Interval Training in Heart Failure Patients With Preserved Ejection Fraction (HIT-HF)Heart Failure With Normal Ejection FractionSwitzerland
-
Norwegian University of Science and TechnologySt. Olavs HospitalRecruiting
-
University of CopenhagenThe Ministry of Science, Technology and Innovation, DenmarkCompletedType 2 DiabetesDenmark
-
Universidade Federal do Rio de JaneiroCompleted
-
Haukeland University HospitalRecruitingBipolar Disorder | Schizophrenia and Related DisordersNorway
-
Western University, CanadaCompleted
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland